Your browser doesn't support javascript.
loading
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin.
Cecchin, E; Perrone, G; Nobili, S; Polesel, J; De Mattia, E; Zanusso, C; Petreni, P; Lonardi, S; Pella, N; D'Andrea, M; Errante, D; Rizzolio, F; Mazzei, T; Landini, I; Mini, E; Toffoli, G.
Afiliação
  • Cecchin E; Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico- National Cancer Institute, Aviano, Italy.
  • Perrone G; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Nobili S; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Polesel J; Epidemiology and Biostatistics Unit, Centro di Riferimento Oncologico- National Cancer Institute, via Franco Gallini, Aviano, Italy.
  • De Mattia E; Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico- National Cancer Institute, Aviano, Italy.
  • Zanusso C; Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico- National Cancer Institute, Aviano, Italy.
  • Petreni P; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Lonardi S; Medical Oncology Unit 1, Istituto Oncologico Veneto- IRCCS, Padua, Italy.
  • Pella N; Medical Oncology Unit, University Hospital, Piazza S. Maria Della Misericordia, Udine, Italy.
  • D'Andrea M; Medical Oncology Unit, 'San Filippo Neri Hospital', Piazza Di S. Maria Della Pieta', Rome, Italy.
  • Errante D; Medical Oncology Unit, Ospedale Civile di Vittorio Veneto, Vittorio, Veneto (TV), Italy.
  • Rizzolio F; Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico- National Cancer Institute, Aviano, Italy.
  • Mazzei T; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Landini I; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Mini E; Section of Internal Medicine , Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Toffoli G; Experimental and Clinical Pharmacology, Centro di Riferimento Oncologico- National Cancer Institute, Aviano, Italy.
Pharmacogenomics J ; 15(3): 219-25, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25331073
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Pirimidinas / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Polimorfismo de Nucleotídeo Único / Metilenotetra-Hidrofolato Redutase (NADPH2) Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Pirimidinas / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Polimorfismo de Nucleotídeo Único / Metilenotetra-Hidrofolato Redutase (NADPH2) Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália